Showing results (211-220 of 976) with videos related to

Sort By:
Pageof 98
NPJ Breast Cancer|May 23, 2026
USP7 inhibition perturbs proteostasis and tumorigenesis in triple-negative breast cancerAhhyun Kim, Priya Gopalakrishnan, Marina Suárez-Pizarro, et al.
NPJ Breast Cancer|May 20, 2026
Targeting microRNA let-7b-5p-mediated aberrant androgen receptor signaling for prevention of hormone receptor-negative breast cancerLeslie Faye Cando, Janvi Sandhu, Zhenlin Ju, et al.
NPJ Breast Cancer|May 15, 2026
Identification and functional validation of EPS15L1 as a key driver of triple-negative breast cancerChun-Chao Wang, Sabareeswaran Krishnan, Yen-Hsun Wang, et al.
NPJ Breast Cancer|March 18, 2026
Androgen receptor localisation and protein interactions provide insight into steroid mediated metabolic shifts in endocrine resistant breast cancerRachel Bleach, Emir Bozkurt, Jingqi Xin, et al.
NPJ Breast Cancer|March 4, 2026
Tracking response to neoadjuvant systemic therapy through circulating tumor DNA analysis in breast cancerAntonio Marra, Sarah H Kim, Fresia Pareja, et al.
NPJ Breast Cancer|March 13, 2026
Artificial intelligence assisted multi-model pathological diagnosis of breast cancer based on multispectral autofluorescence imagesJiahong Sun, Jianqiao Ye, Siyi Chen, et al.
NPJ Breast Cancer|April 9, 2026
Stromal-based proteome data improve stratification of hormone receptor-positive breast cancerKenneth Finne, Silje Kjølle, Magdalena Ríos Romero, et al.
NPJ Breast Cancer|April 11, 2026
PARP inhibition with olaparib and talazoparib for HER2-negative advanced breast cancer-Results from the prospective PRAEGNANT registryManuel Hörner, Andreas Hartkopf, Nelson John, et al.
NPJ Breast Cancer|April 21, 2026
Multimodal analysis of a rare BARD1 missense variant suggests its pathogenicity is conditionalFiona Chan-Pak-Choon, Yuandi Gao, José Camacho-Valenzuela, et al.
NPJ Breast Cancer|June 2, 2026
Neoadjuvant pembrolizumab plus chemotherapy in germline BRCA-mutated early triple-negative breast cancer: a multicenter real-world cohortMonique Celeste Tavares, Flávia C Balint, Romualdo Barroso-Sousa, et al.
Pageof 98